Animals treated between 15th and 30th days of CKD with LOS or ASC monotherapies or with ASC + LOS association showed a numerical reduction of both INT% and interstitial α-SMA which was equivalent among all treated groups. Here, ACTA1 is linked to chronic kidney disease.